chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: 73yo male with hx of CAD,HF, COPD,HTN, HDL,PVCs died on 6/27/21 location & circumstances unknown. Pt also received covid vaccines on 2/12/21 & 3/5/21 from outside source. Not able to assess given lack of information if vaccines were related to pt's death but given timeframe likely not related.
This spontaneous report as received from a nurse practitioner refers to a 5 year old patient. The patient's pertinent medical history was not reported. On 20-APR-2010 the patient was vaccinated with ZOSTAVAX plague-forming units (PFU). On 12-MAY-2014, patient received ZOSTAVAX instead of a second dose of VARIVAX (Merck). No adverse symptoms reported. The outcome of patient received ZOSTAVAX instead of a second dose of VARIVAX (Merck) and no adverse symptoms reported was unknown. Additional information has been requested.
pt recvd vax & exp h/a, soreness all over body; these sx have persisted intermittently since; seem worse p/subsequent dose of vax; c/o rash-painful red bumps under lt arm, easy bruising, fever, chills, abd pain, nausea, anorexia, SOB, swell
Patient reports symmetrical rash on anterior aspect of neck and fatigue that started 06/15/17 Dr. recommended OTC BENADRYL Q6h and return to clinic if not improved by one day.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE NEUROPATHY 3/20/2022 -- RECURRENCE OF SAME SYMPTOMS
Client was seen on 1/13/21 for dose #1 of Moderna Covid vaccine.  She stated on 1/20/21 she developed an oval, red, itchy rash about 3" x 2" around injection site that was warm to the touch. She stated she placed hydrocortisone cream on the area and the rash went away by the next day.
I got up that morning and stopped by restaurant and got me a orange juice and coffee. I got very sick and nauseous. I started itching and whelping up very badly. So, I went to work but had to leave early because I threw up and the itching was even worse. So, my husband took me to the ER and they gave me Benadryl, my blood pressure was very high my sugar was very high also. so I was sent home from ER.
This spontaneous report was received from an unspecified reporter via an online article published and refers to a 606 patients of unknown age and gender who reported the events via Vaccine Adverse Event Reporting System. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses of quadrivalent HPV vaccine (manufacturer unknown) (dose, route of administration, anatomical location, lot # and expiration date were not reported). On unknown dates, the patients experienced an abnormal Papanicolaou smear (Pap Smear) test result. The outcome of the events was unknown. The relatedness between the events and quadrivalent HPV vaccine (manufacturer unknown) was not reported. This is one of several reports received from the same source. Additional information is not expected as no contact details were provided.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 22-AUG-2016, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance for the long term prevention of shingles (dose, route, and lot number not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. In 2016, the patient was treated for the onset of a vesicular rash, which was diagnosed as herpes zoster or shingles. Later in 2016, the patient sought subsequent treatment for the onset of a severe vesicular rash accompanied, which was diagnosed as herpes zoster or shingles. In 2017, the patient sought additional treatment for the onset of a severe vesicular rash accompanied, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX vaccine for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
very congested; hard for me to breathe; cant taste food was reported as worsened.; Tightness in chest; heavy cough was reported as worsened.; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration, administered in left arm on 06Aug2021 11:00 (at the age of 37-year-old) (Batch/Lot Number: EW0164) as dose 1, single for covid-19 immunisation. The patient had no medical history and no concomitant medications. The patient had no history of all previous immunization with the Pfizer vaccine considered as suspect and no additional vaccines administered on the same date as the bnt162b2. On an unspecified date, the patient was very congested and hard for her to breathe. On 07Aug2021, the patient experienced heavy cough. On 09Aug2021, the patient had tightness in her chest. On 10Aug2021, the patient had can't taste her food was reported as worsened. The patient reported that she could taste her food yesterday but not today. The events did not required a visit to emergency room and physician office. Patient was referred to a healthcare provider (HCP) for medical evaluation. The patient asked if she were to be tested again for Covid, would the vaccine cause her to have a false positive. Prior vaccinations (within 4 weeks) was none and no events following prior vaccinations. Outcome of events heavy cough was reported as worsened, cant taste food was reported as worsened was not recovered; tightness in chest was recovering; and outcome of the rest of events was unknown.
Abdominal cramping, chills, arm soreness & swelling Narrative: Within 3 hours, having abdominal cramping, nausea and diarrhea x3, employee advised to monitor temp, may need COVID testing. The next day developed chills, fever, muscle aches, lethargy and sleepiness which lasted 48 hours; injection site soreness and swelling, states unable to move arm which last 24 hours; community test for COVID, negative.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Apr2022 at 12:00 as DOSE 4 (BOOSTER), single (batch/lot number: unknown) at the age of 70 years, administered in the left arm for COVID-19 immunization; covid-19 vaccine (COVID-19 VACCINE), as DOSE 1, SINGLE (batch/lot number: unknown), as DOSE 2, SINGLE (batch/lot number: unknown) and as DOSE 3 (BOOSTER), SINGLE (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history included: "Lichen planus" (unspecified if ongoing), notes: in hair. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19." The patient underwent the following laboratory tests and procedures: Covid-19 test (SARS-CoV-2 test): Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of Drug ineffective, Covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
102.5 temp., off balance and brain fog.    Fine two days, then down again with same symptoms and 99 temp.  Have had no temp since, but brain fog and off balance like having gotten off a boat and sea legs, occasional nausea.  All lab tests fine.
The patient states her arm that she received the vaccine in started itching on 6/1/2021 and has red blotches. She states it continues to itch and burn. Reports no open skin areas.
difficulty breathing; extremely congested; nose is constantly running; feels like chest is full of fluid; sleepy for one day; really tired; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), NASAL CONGESTION (extremely congested), RHINORRHOEA (nose is constantly running), CHEST DISCOMFORT (feels like chest is full of fluid) and SOMNOLENCE (sleepy for one day) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Colon cancer. Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN, FLUOXETINE HYDROCHLORIDE (PROZAC), COLECALCIFEROL (VIT D [COLECALCIFEROL]) and LISINOPRIL for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (difficulty breathing), NASAL CONGESTION (extremely congested), RHINORRHOEA (nose is constantly running), CHEST DISCOMFORT (feels like chest is full of fluid), SOMNOLENCE (sleepy for one day) and FATIGUE (really tired). At the time of the report, DYSPNOEA (difficulty breathing), NASAL CONGESTION (extremely congested), RHINORRHOEA (nose is constantly running), CHEST DISCOMFORT (feels like chest is full of fluid), SOMNOLENCE (sleepy for one day) and FATIGUE (really tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
This spontaneous report as received from a physician and a registered nurse refers to a 3 year old female child patient. The patient was subcutaneously vaccinated at lower right arm with 0.5ml of M-M-R II (Lot#/Exp:668015/0810Z/10-JUN-2012) on 07-AUG-2012 "today". No other co-suspects were reported. No concomitant medications were reported. The physician reported that the patient received an expired M-M-R II on an unspecified date. No adverse symptoms reported. It was unspecified whether the patient had sought medical attention or not. No treatment information was reported. At the time of reporting the outcome was unknown. Additional information has been requested.
Headache, sore throat, lung congestion (hacking up green mucas), dizzy, tired, chills.
After rcvd shot 1-2 later started having sever pain in arm that shot down to his leg. Started feeling weak nauseated, Been in bed for 2 days. can not barely walk. started having muscle pain in hand. Also had left headache. chills or fever. Might be calling HCP to ask about symptoms. Did have the shingles a few years ago. Asked HCP if should get the shot and HCP advised yes.
Systemic: Abdominal Pain-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Hypertension-Medium, Systemic: Nausea-Medium, Systemic: Tachycardia-Medium, Systemic: Weakness-Medium, Additional Details: Pt reported symptoms within 2 minutes of injection.  Benadry 50 mg po given. vitals obtained. BP increased to 165/95 and p118.  consulted with pharmacist.  911 called. pt chose to go to the hospital  injection given at 1429, reported symptoms at 1431, 1433 benadryl given, 1440 911 called, 1453 ems arrives, 1501 pt leaves  via ambulance.
Patient denoted altered vision (seeing red light briefly), profuse sweating [arms, chest, and face], and feeling nauseous.
pt recvd vax & cried for 5 hrs, inconsolable except attempt to feed; not really high pitch fr 4:30pm-9:30pm; low grade fever; not enough to take t;
10 minutes after receiving vaccines, patient experienced itchy sensation in throat, difficulty breathing, swelling in eyes. Tx - 25mg Benadryl; 30mg Oxapred
Vertigo; around his eye was black from the nose and all around the left eye/ Nose is all black and blue; Top of right eye - eyelid is black; Dizziness with position changes; Pain on the left forehead - right above the eye/ Headache; nausea/ nauseous; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VERTIGO (Vertigo), SKIN DISCOLOURATION (around his eye was black from the nose and all around the left eye/ Nose is all black and blue), EYELID DISORDER (Top of right eye - eyelid is black), DIZZINESS POSTURAL (Dizziness with position changes) and HEADACHE (Pain on the left forehead - right above the eye/ Headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced VERTIGO (Vertigo), SKIN DISCOLOURATION (around his eye was black from the nose and all around the left eye/ Nose is all black and blue), EYELID DISORDER (Top of right eye - eyelid is black), DIZZINESS POSTURAL (Dizziness with position changes), HEADACHE (Pain on the left forehead - right above the eye/ Headache) and NAUSEA (nausea/ nauseous). At the time of the report, VERTIGO (Vertigo), EYELID DISORDER (Top of right eye - eyelid is black) and HEADACHE (Pain on the left forehead - right above the eye/ Headache) had resolved, SKIN DISCOLOURATION (around his eye was black from the nose and all around the left eye/ Nose is all black and blue) and DIZZINESS POSTURAL (Dizziness with position changes) outcome was unknown and NAUSEA (nausea/ nauseous) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: negative (Negative) Negative.         Black eye resolved on unreported date. On  06/05/2021, the patient awoke with a Black eye (left) again. No Relevant concomitant medications was reported. Treatment was not taken by the patient.   This case was linked to MOD-2021-067353, MOD-2021-209386, MOD-2021-244811 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Follow up received on 16MAY- 2021. Non significant follow up On 05-Jun-2021: Follow up received on 05-JUN-2021, updated on outcomes of events from unknown to recovered and recovering. Details of first dose and adverse events experienced by his wife was updated.
felt like she was going to leave this world; aches; Chills; headache; arm was swollen at injection site; arm was red  and splotchy at iinjection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like she was going to leave this world), PAIN (aches), CHILLS (Chills), HEADACHE (headache) and VACCINATION SITE SWELLING (arm was swollen at injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt like she was going to leave this world), PAIN (aches), CHILLS (Chills), HEADACHE (headache), VACCINATION SITE SWELLING (arm was swollen at injection site) and VACCINATION SITE ERYTHEMA (arm was red  and splotchy at iinjection site). At the time of the report, FEELING ABNORMAL (felt like she was going to leave this world), PAIN (aches), CHILLS (Chills), HEADACHE (headache), VACCINATION SITE SWELLING (arm was swollen at injection site) and VACCINATION SITE ERYTHEMA (arm was red  and splotchy at iinjection site) outcome was unknown.            No concomitant medications and treatment information were reported.   This case was linked to MOD21-060067, MOD-2021-062398 (Patient Link).
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Seizure-Medium, Systemic: Shakiness-Severe, Systemic: Weakness-Medium
Pt had pustule form 10 days after VARIVAX given. One pustule at vaccination site, one on forehead, (L) shoulder, and ankle. No other symptoms. Pt's mother was advised to use anti-itch cream (BENADRYL) and antibiotic cream.
This spontaneous report was received from a pharmacist, and refers to a 20 year old male patient. The patient's medical history, concurrent conditions, drug reactions, allergies, and concomitant therapies were not reported. On 05-JAN-2016 (also reported as "one year ago"), the patient was vaccinated with one dose of GARDASIL 9 for the first time, intramuscular, for prophylaxis (lot # and expiration date were unspecified). No adverse effects were reported. The reporter stated that, at the time of reporting, the patient was at the pharmacy to receive the second dose. Additional information has been requested.
8 patients total at his facility who passed within 6 months after getting the Pfizer Covid-19 vaccine from hypoxic conditions; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP) from medical information team reporting similar events under the same suspect product for 8 patients. This is one of 8 reports.  An elderly patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as single dose for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOXIA (death, medically significant), outcome "fatal", described as "8 patients total at his facility who passed within 6 months after getting the Pfizer Covid-19 vaccine from hypoxic conditions". The patient underwent the following laboratory tests and procedures: oxygen saturation: 60-80 %, notes: Pulse oxygen saturation levels ranged 60-80%; sars-cov-2 test: negative, notes: 4 tested negative for Covid-19. The patient date of death was unknown. The reported cause of death was hypoxia. It was not reported if an autopsy was performed.   The lot number for BNT162B2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200376657 same reporter/drug, different patient with similar event; Reported Cause(s) of Death: 8 patients total at his facility who passed within 6 months after getting the Pfizer Covid-19 vaccine from hypoxic conditions
Muscle pain and entire body ache for more than 48 hours; Muscle pain and entire body ache for more than 48 hours; Dose received: 3; This is a spontaneous report received from non-contactable reporter (Consumer or other non-HCP).  The reporter is the patient.  A 36-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Dec2021 (Lot number: unknown) at the age of 36 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Latex allergy" (unspecified if ongoing), notes: Known allergy: Latex. Concomitant medications included: VITAMIN C; VITAMIN D and IBUPROFEN. Vaccination history included: bnt162b2 (DOSE 1, SINGLE, Lot Number: Unknown, Route of Administration: Unknown), administration date: 28Jan2021, when the patient was 35 years old, for COVID-19 immunisation and bnt162b2 (DOSE 2, SINGLE, Lot Number: Unknown, Route of Administration: Unknown, Anatomical Location: Left arm), administration date: 18Feb2021, when the patient was 35 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 03Dec2021, outcome "unknown", described as "Dose received: 3"; MYALGIA (non-serious), PAIN (non-serious) all with onset 04Dec2021, outcome "recovering", and all described as "Muscle pain and entire body ache for more than 48 hours".  Therapeutic measures were not taken as a result of myalgia and pain.  Additional Information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Physician ordered the BIVALENT Pfizer vaccine as the 1st dose in the primary series. Patient was previously unvaccinated. No adverse events occurred, but the ordering and verifying of the vaccine was incorrect. Patient should have received the monovalent as the first dose.
Arm Pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient herself. The age at vaccination was not reported. The patient received 1st dose in left arm and her arm hurt. The reporter did not consent to follow-up. For tolerance of 2nd dose, refer case This case had been linked to the case US2019187014 and --, reported by the same reporter.
I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/19/2022 SYSTOLIC HEART FAILURE, ACUTE J96.00 ACUTE RESPIRATORY FAILURE 1/19/2022 SYSTOLIC HEART FAILURE, ACUTE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/14/2022 SYSTOLIC HEART FAILURE, ACUTE R09.02 HYPOXEMIA 1/18/2022 SYSTOLIC HEART FAILURE, ACUTE I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/19/2022 APHASIA J96.00 ACUTE RESPIRATORY FAILURE 1/19/2022 APHASIA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/14/2022 APHASIA R09.02 HYPOXEMIA 1/18/2022 APHASIA
I received the tetanus pertussis shot in Oct 30, 2013. In Jan I got a cough that lasted til April. My body stiffened up neck, jaw, shoulders, hips, legs and I lost my vision in my right eye. Only 20/100 vision. I was medically disqualified from my job.
Information has been received from a family member concerning a male who was vaccinated with varicella virus vaccine live (manufacturer unspecified). Subsequently, after taking an unknown chicken pox vaccine several years ago he developed the chicken pox. Additional information has been requested.